Dr. Oppenheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bld 1560 Brmp Fcrf Nci
Frederick, MD 21701Phone+1 301-846-1551Fax+1 301-846-7042
Education & Training
Columbia University Vagelos College of Physicians and SurgeonsClass of 1960
University of Alabama Medical CenterResidency, Allergy and Immunology
Certifications & Licensure
MD State Medical License 1975 - 2015- American Board of Allergy and Immunology Allergy & Immunology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Publications & Presentations
PubMed
- 6 citationsTNFR2 antagonistic antibody induces the death of tumor infiltrating CD4Foxp3regulatory T cells.Tianzhen He, Yibo Chen, De Yang, Md Sahidul Islam, Chon-Kit Chou
Cellular Oncology. 2023-02-01 - 189 citationsInterleukin-8: An evolving chemokine.Kouji Matsushima, De Yang, Joost J Oppenheim
Cytokine. 2022-05-01 - 58 citationsAlpha synuclein, the culprit in Parkinson disease, is required for normal immune function.Md Masud Alam, De Yang, Xiao-Qing Li, Jia Liu, Timothy Carrel Back
Cell Reports. 2022-01-11
Press Mentions
A Personal Perspective on My Scientific CareerDecember 1st, 2022
Massachusetts General Researchers Identify New Target for Cancer ImmunotherapyJanuary 17th, 2017
Negative Regulation of Human Immune Deficiency Virus Replication in MonocytesMay 12th, 1990
Grant Support
- Studies Of Chemokine-Receptor Interactions With Chemokines And AlarminsNational Cancer Institute2010–2011
- Role Of T Regulatory Suppression In Autoimmunity And CancerNational Cancer Institute2010–2011
- Consequences Of Receptor Cross TALK On Inflammation And AlgesiaNational Cancer Institute2010–2011
- Studies Of Chemokine-Receptor Interactions With Chemokines And AlarminsDivision Of Basic Sciences - Nci2009
- Role Of T Regulatory Suppression In Autoimmunity And CancerDivision Of Basic Sciences - Nci2009
- Consequences Of Receptor Cross TALK On Inflammation And AlgesiaDivision Of Basic Sciences - Nci2009
- Studies Of Chemokine-Receptor Interactions With Chemokines And AlarminsNational Cancer Institute2008
- Role Of T Regulatory Suppression In Autoimmunity And CancerNational Cancer Institute2007–2008
- Consequences Of Receptor Cross TALK On Inflammation And AlgesiaNational Cancer Institute2007–2008
- Consequences Of Chemokine-Receptor Interactions With Chemokines And Chemokine MINational Cancer Institute2007
- Role Of T Regulatory Suppression In Autoimmunity And CanDivision Of Basic Sciences - Nci2006
- Consequences Of Receptor Cross TALK On Inflammation AndDivision Of Basic Sciences - Nci2006
- Consequences Of Chemokine-Receptor Interactions With CHEDivision Of Basic Sciences - Nci2005–2006
- Modulating T Cell Tolerance To Elicit Tumor Immunity AndDivision Of Basic Sciences - Nci2004
- Chemokine-Receptor Interactions With Chemokines/MimicsDivision Of Basic Sciences - Nci2004
- Consequences Of Chemokine-Receptor InteractionsDivision Of Basic Sciences - Nci2001–2003
- Consequences Of Chemokine-Receptor Interactions: ImmuneDivision Of Basic Sciences - Nci2002
- Consequences Of Chemokine-Receptor Interactions: Immune Activation And AngiogeneDivision Of Basic Sciences - Nci2000
- Consequences Of Chemokine-Receptor Interactions: Immune Activation And AngiogenesDivision Of Basic Sciences - Nci1999
- Receptor Activation And Desensitization By ChemokinesDivision Of Basic Sciences - Nci1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
